Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years (terminated appraisal) TA1104 22 October 2025 22 October 2025 Clascoterone for treating ...
ADC12 prices remain firm with cost support, but weak high-price transactions will limit upside room. [SMM Analysis] GAC, Huawei Digital Power forge strategic alliance to boost EV performance and ...
Despite occasional market volatility and significant regulatory uncertainties, VeChain demonstrates resilience and a strong value proposition, which is vital for the vechain ecosystem positioning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback